mRNA BNT162b Vaccine Elicited Higher Antibody and CD4(+) T-Cell Responses than Patients with Mild COVID-19

We compared the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection. We analysed 37 post-COVID-19 patients (15 with pneumonia and 22 with mild symptoms) and 20 vaccinated subjects. Anti-Spike IgG and neutralising antibodies were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zavaglio, Federica, Cassaniti, Irene, Sammartino, Josè Camilla, Tonello, Stelvio, Sainaghi, Pier Paolo, Novelli, Viola, Meloni, Federica, Lilleri, Daniele, Baldanti, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228401/
https://www.ncbi.nlm.nih.gov/pubmed/35744768
http://dx.doi.org/10.3390/microorganisms10061250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228401/
https://www.ncbi.nlm.nih.gov/pubmed/35744768
http://dx.doi.org/10.3390/microorganisms10061250

Ejemplares similares